Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00669806%3A_____%2F04%3A00000203" target="_blank" >RIV/00669806:_____/04:00000203 - isvavai.cz</a>

Alternative codes found

RIV/00216208:11140/04:00001132

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Fibrate treatment and prevalence risk of mild hyperhomocysteinaemia in clinical coronary heart disease patients

Original language description

Fibrate treatment was associated with significant increase in prevalence risk of mild hyperhomocysteinemia in coronary patients, independently from conventional confounders.

Czech name

Léčba fibráty a výskyt rizika mírné homocysteinémie u pacientů se srdečním onemocněním

Czech description

Léčba fibráty a výskyt rizika mírné homocysteinémie u pacientů se srdečním onemocněním.

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FA - Cardiovascular diseases including cardio-surgery

OECD FORD branch

—

Project

<a href="/en/project/NL6817" target="_blank" >NL6817: The influence of fibrates on homocystein metabolism and its impact on endothelial dysfunction and coagulation status in dyslipidemic patients.</a><br>

Continuities

P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year

2004

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

European Journal of Cardiovascular Prevention and Rehabilitation

ISSN

1741-8267

e-ISSN

—

Volume of the periodical

11

Issue of the periodical within the volume

3

Country of publishing house

GB - UNITED KINGDOM

Number of pages

6

Pages from-to

244-249

UT code for WoS article

—

EID of the result in the Scopus database

—